Parsabiv
Payments companies reported to CMS as associated with Parsabiv. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Parsabiv, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Parsabiv
These are the largest totals companies reported as associated with Parsabiv. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Henner | Pittsfield, MA | Nephrology (Internal Medicine) | $17,000.50 |
| Deborah Glidden | Winter Park, FL | Nurse Practitioner | $12,125.63 |
| Rodolfo Batarse | Rancho Mirage, CA | Nephrology (Internal Medicine) | $8,542.38 |
| Abdul Abdellatif | Webster, TX | Nephrology (Internal Medicine) | $4,874.42 |
| Michael Quadrini | Huntsville, AL | Nephrology (Internal Medicine) | $4,864.61 |
| Stuart Sprague | Evanston, IL | Nephrology (Internal Medicine) | $3,798.14 |
| Kevin Martin | St Louis, MO | Nephrology (Internal Medicine) | $3,750.00 |
| Christos Mantzoros | Boston, MA | Endocrinology, Diabetes & Metabolism | $1,430.00 |
| Susan Quaggin | Chicago, IL | Nephrology (Internal Medicine) | $1,058.00 |
| Marcia Ryder | Syracuse, NY | Nurse Practitioner | $1,029.46 |
Prescribed Parsabiv?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.